... Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow ... conditioning regimen in context with BU/CY2. Bone Marrow Transplant ...
... Oral mucositis . Oral Oncol 2010 ; 46 ( 6 ) : 452–456 . 2. National Institutes of Health Consensus Development Panel ... patients treated with radiotherapy with or without chemotherapy : Demonstration of increased frequency ...
... chemotherapy-induced mucositis and dermatitis in head and neck cancer. Mol Clin Oncol 2017;6(6):931–6. 13. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004;4(4):277–84. 14. Blijlevens N, Schwenkglenks M, Bacon P, et al.
... oral mucositis for patients with cancer receiving treatment . Cochrane Database Syst Rev. 2007 Oct 17 ; ( 4 ) ... Group . Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by ...
... High - dose ida- rubicin , cyclophosphamide and melphalan as condi- tioning for autologous stem cell transplantation increases treatment - related mortality in patients with multiple myeloma : results of a randomised study . Br J ...
... mucositis assessment tools to both advance the science of oral toxicities and to improve patient care. This clinical ... patients treated with radiotherapy with or without chemotherapy. Cancer. 2008;113:2704-2713. 5. Barasch A ...